comprehensive -WSS

comprehensive

author：fashion 2025-08-28 04:23:20 - browse：7

a person uses a smart phone with both fingers in the dark – first opinion coverage from STAT — Adobe

In May, a National Public Radio story asked, “Can a chatbot help people with eating disorders as well as another human?”

It focused on a chatbot that we developed to prevent eating disorders and help people with body image concerns and who are otherwise not likely to have access to other resources. We’ve committed our careers to increasing detection of eating disorders and access to care, and we received research funding from the National Eating Disorders Association (NEDA) to create and evaluate a chatbot called Tessa in hopes of preventing eating disorders and helping to address the problem that once individuals develop eating disorders, less than 20% ever receive any care.

The NPR story and coverage that followed led to a tremendous backlash for a couple of reasons. Some of those reasons are fair and are related to a technical problem — more on that in a minute.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Telehealth options flood the market as retailers push virtual care

focus

WSS

Readout Newsletter: What happened with Sarepta's Duchenne data

FDA has safety concerns on CRISPR

Testing for cancer recurrence creates a new limbo for patients

Senate panel to vote on hospitals, PBMs, prisoner care

Traditional Chinese medicine benefits explored in new JAMA study

First Opinion Podcast: How to protect health care in times of war

hotspot

comprehensive

entertainment

As demand for Covid shots wanes, Moderna seeks its next success

Physician subsidies by hospitals soar in wake of No Surprises Act

Medicare details structure of new drug price negotiation program

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Medicare details structure of new drug price negotiation program

Senate panel to vote on hospitals, PBMs, prisoner care

Alkermes shareholders re

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Hepatitis C has a cure — but many Americans still lack access to it

Eli Lilly to pay $200M for Beam’s stake in gene

entertainment

Testing for cancer recurrence creates a new limbo for patients

Meta's Zuckerberg and Chan on track to put $50 billion into science

First Opinion Podcast: How to protect health care in times of war

Medtronic CEO on promising devices for diabetes, hypertension

First Opinion Podcast: How to protect health care in times of war

Readout Newsletter: New research from Sanofi, Regeneron, etc.

focus

explore

knowledge

entertainment